Court Blasts FDA Over Pravachol Generic Launch
The FDA abused its discretion by triggering too early Teva Pharmaceutical Inc.'s 180-day market exclusivity for a generic cholesterol drug, according to a federal court's order granting injunctive relief to the...To view the full article, register now.
Already a subscriber? Click here to view full article